Self-replicating RNA molecule from hepatitis C virus

Details for Australian Patent Application No. 2002218906 (hide)

Owner Boehringer Ingelheim (Canada) Ltd.

Inventors Kukolj, George; Pause, Arnim

Agent Davies Collison Cave

Pub. Number AU-B-2002218906

PCT Pub. Number WO2002/052015

Priority 60/257,857 22.12.00 US

Filing date 20 December 2001

Wipo publication date 8 July 2002

Acceptance publication date 3 August 2006

International Classifications

C12N 15/51 (2006.01) Mutation or genetic engineering - Hepatitis viruses

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

C12N 15/40 (2006.01) Mutation or genetic engineering - Proteins from RNA viruses, e.g. flaviviruses

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12Q 1/70 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

Event Publications

23 January 2003 Application Open to Public Inspection

  Published as AU-B-2002218906

3 August 2006 Application Accepted

  Published as AU-B-2002218906

30 November 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002218907-SHARED PIXEL ELECTROLUMINESCENT DISPLAY DRIVER SYSTEM

2002218905